Change in disease-specific measures and functional outcome during the study period
| Variable | Baseline median (range) | Week 48 median (range) | p Value |
|---|---|---|---|
| *Significant reduction from baseline to study end. | |||
| ESR (mm/1st h) | 24 (1–72) | 22 (2–75) | 0.117 |
| CRP (mg/l) | 20 (<6–85) | 8 (<6–41) | 0.004* |
| Articular index | 6 (0–24) | 4 (0–16) | 0.92 |
| Haemoglobin (g/l) | 127 (102–147) | 127 (100–151) | 0.779 |
| HAQ | 1.75 (0.5–2.875) | 1.75 (0–2.75) | 0.558 |